2010
DOI: 10.1016/j.cbi.2010.07.015
|View full text |Cite
|
Sign up to set email alerts
|

Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
57
0
1

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 66 publications
(60 citation statements)
references
References 44 publications
2
57
0
1
Order By: Relevance
“…Recent reports have shown that temozolomide killed brain tumor cells with greater efficiency when used in combination with epigallocatechin gallate (EGCG), a component of green tea or quercetin [12,40]. However, in our studies, rosehip extracts consistently demonstrated a greater capacity to reduce cell prolifera-tion than temozolomide (Figure 10).…”
Section: Discussionmentioning
confidence: 47%
See 2 more Smart Citations
“…Recent reports have shown that temozolomide killed brain tumor cells with greater efficiency when used in combination with epigallocatechin gallate (EGCG), a component of green tea or quercetin [12,40]. However, in our studies, rosehip extracts consistently demonstrated a greater capacity to reduce cell prolifera-tion than temozolomide (Figure 10).…”
Section: Discussionmentioning
confidence: 47%
“…Quercetin, a flavonoid, has been reported as one of the active ingredients that can be elucidated from rosehip extracts [12,13,38]. Purified quercetin has been tested against U-87MG, U-251 MG and A-172 cells [38].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The combination of quercetin and TMZ has been reported to treat the human astrocytoma cell line MOGGCCM (WHO grade III). The results indicate that quercetin acts in synergy with TMZ and that when both drugs are used in combination, rather than in separate pharmacological application, they more effectively induce programmed cell death [24] . However, glioblastoma cells (WHO grade IV) are usually TMZ-insensitive and multidrug resistant; thus, investigating the effects of quercetin and TMZ on glioblastoma cell lines is more meaningful.…”
Section: Discussionmentioning
confidence: 79%
“…Data show means±standard errors calculated from three independent experiments. Asterisk (*) indicates significant change of protein expression using one-way ANOVA and Dunnett's posttest glioma cell line (MOGGCCM, astrocytoma GIII), a previous study showed an inhibition of HSPB1 and HSPA1A expression after treatment with TMZ, alone or in combination with quercetine (Jakubowicz-Gil et al 2010). This is indicating that TMZ is inducing different responses in different glioma cells, and the molecular heterogeneity may be important in understanding how current therapeutic treatments fail to target cells in the GBM tumor mass thereby selecting for resistant cells that can result in disease recurrence and poor survival (Chorny et al 2000).…”
Section: Discussionmentioning
confidence: 99%